Breaking News Novan (NASDAQ: NOVN) Drops Hard After Molluscum Contagiosum Trial Failed To Meet Primary Endpoints Novan Inc. (NASDAQ: NOVN) was a big loser in Friday’s trading session. The stock gapped down and closed the day at a loss of 73.05%. This followed its announcement that, efficacy results from its Phase 3B program dubbed SIMPLE had not met